Children's Health

Citations

1. U.S. Preventive Services Task Force (2008). Screening for phenylketonuria (PKU). Available online: http://www.uspreventiveservicestaskforce.org/uspstf/uspsspku.htm.

2. National Institutes of Health (2000). Phenylketonuria (PKU): Screening and management. NIH Consensus Statement, 17(3): 1-33.

Other Works Consulted

• Aminoff M (2009). Metabolic disorders section of Neurologic disorders. In RK Creasy et al., eds., Creasy and Resnik's Maternal-Fetal Medicine, 6th ed., pp. 1101-1102. Philadelphia: Saunders Elsevier.

• Durkin MS, et al. (2008). Childhood cognitive disability. In RB Wallace et al., eds., Wallace/Maxcy-Rosenau-Last Public Health and Preventive Medicine, 15th ed., pp. 1173-1183. New York: McGraw-Hill.

• Feillet F, et al. (2010). Challenges and pitfalls in the management of phenylketonuria. Pediatrics, 126(2): 333-341.

• Poustie VJ, Wildgoose J (2010). Dietary interventions for phenylketonuria. Cochrane Database of Systematic Reviews (1).

• Sapropterin (Kuvan) for phenylketonuria (2008). Medical Letter on Drugs and Therapeutics, 50(1287): 43-44.

• Schwahn BC (2011). Hyperphenylalaninemias. In CD Rudolph et al., eds., Rudolph's Pediatrics, 22nd ed., pp. 561-563. New York: McGraw-Hill.

• Somaraju UR, Merrin M (2010). Sapropterin dihydrochloride for phenylketonuria. Cochrane Database of Systematic Reviews (6).

• Thomas JA, Van Hove JLK (2011). Phenylketonuria and the hyperphenylalaninemias section of Inborn errors of metabolism. In WW Hay Jr et al., eds., Current Diagnosis and Treatment: Pediatrics, 20th ed., pp. 1002-1003. New York: McGraw-Hill.